Kalmeda Tinnitus Study

Kalmeda Tinnitus Study - TKS

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00022973

Enrollment

150

Registered

2020-10-09

Start date

2020-08-07

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

H93.1

Interventions

Group 1: The intervention group uses the Kalmeda Tinnitus App immediately. Group 2: The control group uses the Kalmeda tinnitus app after a 3 month waiting period and receives general information abou

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Chronic tinnitus longer than 3 months

Exclusion criteria

Exclusion criteria: psychological diseases

Design outcomes

Primary

Measure	Time frame
The primary outcome variable of the study is the total score of the tinnitus questionnaire by Göbel and Hiller. It is primarily used to assess the effectiveness of Kalmeda. The primary endpoint is defined as the tinnitus burden after three months.	—

Secondary

Measure	Time frame
As secondary endpoints, the respective changes in tinnitus burden, depression tendency, stress experience and self-efficacy after 12 months (control group) or 9 months (intervention group) are selected.	—

Countries

Germany

Contacts

Public ContactRoland Piers Uso Walter

HNO-Praxis

hnowalter@t-online.de0203355310

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 5, 2026